DK0760375T3 - Antitumor-indolopyrrolocarbazolderivater - Google Patents

Antitumor-indolopyrrolocarbazolderivater

Info

Publication number
DK0760375T3
DK0760375T3 DK95917506T DK95917506T DK0760375T3 DK 0760375 T3 DK0760375 T3 DK 0760375T3 DK 95917506 T DK95917506 T DK 95917506T DK 95917506 T DK95917506 T DK 95917506T DK 0760375 T3 DK0760375 T3 DK 0760375T3
Authority
DK
Denmark
Prior art keywords
antitumor
indolopyrrolocarbazole derivatives
compounds
indolopyrrolocarbazole
derivatives
Prior art date
Application number
DK95917506T
Other languages
Danish (da)
English (en)
Inventor
Katsuhisa Kojiri
Hisao Kondo
Hiroharu Arakawa
Mitsuru Ohkubo
Hiroyuki Suda
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Priority claimed from PCT/JP1995/000868 external-priority patent/WO1995030682A1/ja
Application granted granted Critical
Publication of DK0760375T3 publication Critical patent/DK0760375T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/12Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/16Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95917506T 1994-05-09 1995-05-02 Antitumor-indolopyrrolocarbazolderivater DK0760375T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11948394 1994-05-09
JP14564894 1994-06-03
PCT/JP1995/000868 WO1995030682A1 (fr) 1994-05-09 1995-05-02 Derive d'indolopyrolocarbazole antitumoral

Publications (1)

Publication Number Publication Date
DK0760375T3 true DK0760375T3 (da) 2003-12-29

Family

ID=26457215

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02018235T DK1264836T3 (da) 1994-05-09 1995-05-02 Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
DK95917506T DK0760375T3 (da) 1994-05-09 1995-05-02 Antitumor-indolopyrrolocarbazolderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02018235T DK1264836T3 (da) 1994-05-09 1995-05-02 Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater

Country Status (14)

Country Link
EP (2) EP0760375B1 (pt)
JP (1) JP3038921B2 (pt)
KR (1) KR100312473B1 (pt)
CN (2) CN1106400C (pt)
AT (2) ATE283863T1 (pt)
AU (1) AU683749B2 (pt)
CA (1) CA2190007C (pt)
CL (1) CL2004001117A1 (pt)
DE (2) DE69533833T2 (pt)
DK (2) DK1264836T3 (pt)
ES (2) ES2230433T3 (pt)
HK (2) HK1000890A1 (pt)
PT (2) PT1264836E (pt)
TW (1) TW313566B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050176968A1 (en) * 2002-08-23 2005-08-11 Atsushi Akao Process for producing indolopyrrolocarbazole derivative
CN101585861B (zh) * 2009-07-03 2012-10-24 复旦大学 N-糖基萘并咔唑化合物及其合成方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
ATE158298T1 (de) * 1990-05-11 1997-10-15 Banyu Pharma Co Ltd Be-13793c-derivat mit antitumorwirkung
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
DE69531686T2 (de) * 1994-06-13 2004-07-15 Banyu Pharmaceutical Co., Ltd. Glycosyltransferase kodierendes gen und seine verwendung
WO1996004293A1 (fr) * 1994-08-02 1996-02-15 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazoles antitumoraux

Also Published As

Publication number Publication date
DE69533833D1 (de) 2005-01-05
DK1264836T3 (da) 2005-03-07
CA2190007A1 (en) 1995-11-16
DE69532198T2 (de) 2004-08-26
CN1153518A (zh) 1997-07-02
EP1264836B1 (en) 2004-12-01
JP3038921B2 (ja) 2000-05-08
EP0760375A1 (en) 1997-03-05
PT1264836E (pt) 2005-02-28
KR100312473B1 (ko) 2002-06-24
HK1067948A1 (en) 2005-04-22
CA2190007C (en) 2003-04-15
EP0760375A4 (en) 2002-03-27
DE69532198D1 (de) 2004-01-08
CN1285605C (zh) 2006-11-22
CN1513865A (zh) 2004-07-21
AU2353595A (en) 1995-11-29
TW313566B (pt) 1997-08-21
ATE283863T1 (de) 2004-12-15
CN1106400C (zh) 2003-04-23
ES2206501T3 (es) 2004-05-16
DE69533833T2 (de) 2005-12-15
HK1000890A1 (en) 2004-01-09
EP0760375B1 (en) 2003-11-26
PT760375E (pt) 2004-04-30
KR970702869A (ko) 1997-06-10
ATE255121T1 (de) 2003-12-15
ES2230433T3 (es) 2005-05-01
EP1264836A1 (en) 2002-12-11
CL2004001117A1 (es) 2005-04-22
AU683749B2 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
DK0582788T3 (da) 7-(Substituerede)-9-[(substitueret glycyl)-amido]-demethyl-6-deoxytetracycliner
NO2011026I2 (no) Eribulin eller et farmasøytisk akseptabelt salt derav
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
ATE128985T1 (de) Hydantoinderivate.
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
AU641686B2 (en) Benzanilides
HK1067948A1 (en) Antitumor indolopyprolocarbazole derivative
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK378087D0 (da) Tetracycliske indolderivater
ES2185708T3 (es) Inhibicion de la biosintesis de leucotrienos con derivados de urea.
DE3772850D1 (de) Thiadiazinon-derivate.